In hepatocytes, vitamin E is secreted via the efflux pathway and is believed to associate with apolipoprotein B (apoB)-lipoproteins extracellularly. The molecular mechanisms involved in the uptake, intracellular trafficking, and secretion of dietary vitamin E by the intestinal cells are unknown. We observed that low concentrations of Tween-40 were better for the solubilization and delivery of vitamin E to differentiated Caco-2 cells, whereas high concentrations of Tween-40 and sera inhibited this uptake. Vitamin E uptake was initially rapid and then reached saturation. Subcellular localization revealed that vitamin E primarily accumulated in microsomal membranes. Oleic acid (OA) treatment, which induces chylomicron assembly and secretion, decreased microsomal membrane-bound vitamin E in a time-dependent manner. To study secretion, differentiated Caco-2 cells were pulse-labeled with vitamin E and chased in the presence and absence of OA. In the absence of OA, vitamin E was associated with intestinal high density lipoprotein (I-HDL), whereas OAtreated cells secreted vitamin E with I-HDL and chylomicrons. No extracellular transfer of vitamin E between these lipoproteins was observed. Glyburide, an antagonist of ABCA1, partially inhibited its secretion with I-HDL, whereas plasma HDL increased vitamin E efflux. An antagonist of microsomal triglyceride transfer protein, brefeldin A, and monensin specifically inhibited vitamin E secretion with chylomicrons. These studies indicate that vitamin E taken up by Caco-2 cells is stored in the microsomal membranes and secreted with chylomicrons and I-HDL. Transport via I-HDL might contribute to vitamin E absorption in patients with abetalipoproteinemia receiving large oral doses of the vitamin. Vitamin E is a major lipid-soluble antioxidant and is an essential nutrient for normal growth and development. Its deficiency results in neurological dysfunction, muscular weakness, and reproductive failure (1-3). Although a diet rich in vegetable oils and whole grains is a sufficient source of vitamin E in normal people (4), deficiency can result because of lipid malabsorption syndromes such as abetalipoproteinemia, a disease in which apolipoprotein B (apoB)-containing lipoproteins (chylomicrons, very low density lipoproteins, and low density lipoproteins) are absent in the plasma (1, 2). High oral doses of vitamin E ameliorate the deficiency and normalize plasma and adipose tissue levels of the vitamin in these patients (5). The mechanisms involved in vitamin E absorption in the absence of apoB-lipoprotein assembly are not known.Current knowledge of intestinal vitamin E absorption is based on human and animal studies involving oral or intraduodenal administration of vitamin E followed by lymph and plasma analysis (1-3, 6-9). Vitamin E uptake by the intestinal cells is believed to be less efficient than that of other fat-soluble vitamins. In most studies, z20-50% of dietary vitamin E is believed to be absorbed (4, 10). In contrast, z80% of dietary vitamin A is absorbed in 24 h...